We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 283

State AGs in the news

  • Dickstein Shapiro LLP
  • -
  • USA
  • -
  • July 24 2014

CWAG held its annual meeting this week in Park City, Utah, which was attended by several members of Dickstein Shapiro's State Attorneys General

PhRMA v FTC: FTC HSR rulemaking in the pharmaceutical industry upheld

  • Chadbourne & Parke LLP
  • -
  • USA
  • -
  • July 22 2014

The United States District Court for the District of Columbia recently upheld the Federal Trade Commission's rulemaking regarding the

Court dismisses suit accusing LSU of fraudulent sweetener patent

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 18 2014

A California federal court has dismissed on jurisdictional grounds Quest Nutrition LLC's lawsuit against Louisiana State University Agricultural

District Court upholds FTC Hart-Scott-Rodino rules for pharmaceutical patent transfers

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 26 2014

A federal court has upheld the validity of the FTC's recent rules for reporting certain transfers of exclusive patent rights in the pharmaceutical

FTC rule targeting pharma licenses is upheld by federal judge

  • Sunstein Kann Murphy & Timbers LLP
  • -
  • USA
  • -
  • June 26 2014

Last November, the Federal Trade Commission ("FTC") announced a rule requiring advance notice of proposed exclusive patent license agreements in the

FTC v. Actavis one year later: uncertainty reigns

  • Fish & Richardson PC
  • -
  • USA
  • -
  • June 24 2014

So-called "pay for delay" patent settlements continue to roil the pharmaceutical industry. I recently spoke on this topic at the 3rd Circuit judicial

DC District Court upholds new HSR rules expanding reporting requirements for pharmaceutical patent licenses

  • Kirkland & Ellis LLP
  • -
  • USA
  • -
  • June 11 2014

On May 30, 2014, the Federal District Court for the District of Columbia upheld recent amendments to the Hart-Scott-Rodino Antitrust Improvements Act

Second Circuit affirms dismissal of RANDantitrust dispute based on foreign activity (Lotes v. Hon Hai Precision)

  • Kelley Drye & Warren LLP
  • -
  • USA
  • -
  • June 5 2014

Yesterday, the Second Circuit in Lotus v. Hon Hai Precision affirmed the district court's dismissal of antitrust and breach of contract claims

Managing antitrust risks in patent licensing post-expiration royalties and package licensing

  • Baker Botts LLP
  • -
  • USA
  • -
  • June 2 2014

Patent owners have considerable freedom to negotiate the subject matter, price, and term in licensing agreements. However, antitrust law has been

European antitrust decisions establish “safe harbour” for willing licensees of standard essential patents

  • Kelley Drye & Warren LLP
  • -
  • USA
  • -
  • April 30 2014

Yesterday, the European Commission issued decisions in two antitrust proceedings centered around the enforcement of standard essential patents (SEPs